Anbio Biotechnology

Medical Instruments & Supplies • Healthcare • Frankfurt am Main, Germany • NNNN (NGM)

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

49 16 0962 47281 Wilhelm Gutbrod Str 21B, Germany

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance

Yahoo Finance • Jan 1

Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st

simplywall.st • Jan 1

Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - TipRanks

TipRanks • Dec 30

Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha

Seeking Alpha • Oct 10

S&P 500 Futures Rise in Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - Barron's

Barron's • Oct 3

Other Medical Instruments & Supplies Companies

View All →

Intuitive Surgical Inc.

$206.27B market cap

Becton Dickinson & Co.

WEST Pharmaceutical Services Inc.

$19.83B market cap

Frequently Asked Questions

Has Anbio Biotechnology had layoffs?

No layoff events have been recorded for Anbio Biotechnology in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Anbio Biotechnology have?

Anbio Biotechnology has approximately 27 employees.

What industry is Anbio Biotechnology in?

Anbio Biotechnology operates in the Medical Instruments & Supplies industry, within the Healthcare sector.

Is Anbio Biotechnology a publicly traded company?

Yes, Anbio Biotechnology is publicly traded under the ticker symbol NNNN on the NGM. The company has a market capitalization of approximately $1.47 billion.

Where is Anbio Biotechnology headquartered?

Anbio Biotechnology is headquartered in Frankfurt am Main, Germany at Wilhelm Gutbrod Str 21B, Germany.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.